Company Filing History:
Years Active: 1998
Title: Shuji Ehara: Innovator in Pharmaceutical Compounds
Introduction
Shuji Ehara is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on Thienotriazolodiazepine compounds. His research focuses on the therapeutic applications of these compounds in treating inflammatory and allergic diseases.
Latest Patents
Shuji Ehara holds 1 patent for his invention titled "Thienotriazolodiazepine compounds and their pharmaceutical use." This patent describes compounds of the formula (1), which are useful as preventive and therapeutic drugs for diseases where cell adhesion plays a critical role. The compounds include pharmaceutically acceptable salts and highlight their potential in medical applications.
Career Highlights
Ehara is associated with Yoshitomi Pharmaceutical Industries, Ltd., where he has been instrumental in advancing pharmaceutical research. His work has contributed to the development of new therapeutic options for patients suffering from various inflammatory conditions.
Collaborations
Some of his notable coworkers include Hiroyuki Sueoka and Haruhito Kobayashi, who have collaborated with him on various projects within the pharmaceutical industry.
Conclusion
Shuji Ehara's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to influence the development of new treatments for inflammatory and allergic diseases.